LLY
Published on 04/16/2026 at 05:09 pm EDT
Health-care companies fell as traders rotated into cyclical sectors, betting on an extension to the U.S.-Iran cease-fire.
Abbott Laboratories shares fell after the maker of baby-food, adult nutrition and other medical products cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected flu season hurt its recent quarter.
Eli Lilly's late-stage clinical trial of a type 2 diabetes treatments showed promise.
Write to Rob Curran at [email protected]
(END) Dow Jones Newswires
04-16-26 1708ET